NCT01720576View on ClinicalTrials.gov

Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786)

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

REGN1033 (SAR391786)

DRUG

Placebo

Trial Locations (2)

Unknown

Daytona Beach

Evansville

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01720576 - Study to Assess the Safety and Tolerability of Multiple Ascending Doses of REGN1033 (SAR391786) | Biotech Hunter | Biotech Hunter